01.02.2002 | Original Article
A Randomized Trial of Sodium Fluoride (60 mg) ± Estrogen in Postmenopausal Osteoporotic Vertebral Fractures: Increased Vertebral Fractures and Peripheral Bone Loss with Sodium Fluoride; Concurrent Estrogen Prevents Peripheral Loss, But Not Vertebral Fractures
Erschienen in: Osteoporosis International | Ausgabe 2/2002
Einloggen, um Zugang zu erhalten